Top Cancer Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global Cancer Companies in United States market cap is $120.67B.
23 Nov 2024, 01:57 UTC
Companies: 166
🇺🇸1 |  | $65.17 | -1.90% | 14.57B | 4.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸2 |  | $67.99 | -2.14% | 12.30B | -7.50% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸3 |  | $49.91 | -2.46% | 9.10B | -16.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸4 |  | $27.59 | 0.44% | 8.78B | 15.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $44.06 | 0.66% | 7.22B | 55.25% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $102.63 | -2.02% | 5.87B | 41.70% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $89.31 | 3.24% | 5.41B | -1.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $77.99 | 1.27% | 4.05B | 42.94% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸9 |  | $13.64 | 2.40% | 3.83B | 3310.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $25.09 | -1.14% | 3.05B | -5.78% | Underperform S&P500 YTD Benchamark | ⚕️💻 Healthtech | - |
🇺🇸11 |  | $10.17 | -2.40% | 2.60B | 27.44% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $35.58 | 0.45% | 2.56B | -1.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $4.55 | 4.12% | 2.47B | 116.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸14 |  | $13.82 | 1.36% | 2.41B | 852.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $6.23 | 2.47% | 2.38B | 641.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸16 |  | $34.75 | -2.88% | 2.24B | -1.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸17 |  | $48.32 | -2.30% | 2.23B | 352.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸18 |  | $18.00 | -0.33% | 1.53B | -15.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸19 |  | $20.26 | 0.50% | 1.50B | 40.01% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸20 |  | $25.39 | 0.26% | 1.40B | -37.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸21 |  | $16.49 | -1.43% | 1.23B | -13.35% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸22 |  | $13.79 | 0.22% | 1.20B | -3.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸23 |  | $24.74 | -0.36% | 1.20B | 138.57% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸24 |  | $24.20 | 3.73% | 997.16M | 3.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸25 |  | $7.58 | -0.26% | 966.16M | -29.62% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸26 |  | $21.49 | -3.98% | 885.65M | 54.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸27 |  | $8.28 | -3.94% | 844.48M | -15.51% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸28 |  | $3.12 | 27.87% | 750.76M | 160.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸29 |  | $17.23 | -0.06% | 737.11M | 70.93% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸30 |  | $11.20 | 1.08% | 651.99M | 32.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸31 |  | $2.90 | -5.54% | 632.04M | 93.33% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸32 |  | $10.21 | 6.02% | 630.92M | 58.05% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸33 |  | $13.57 | -5.17% | 591.95M | 101.34% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸34 |  | $10.67 | 5.64% | 582.07M | 16.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸35 |  | $16.65 | -5.83% | 547.68M | 100.60% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸36 |  | $2.96 | 2.78% | 498.10M | -7.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸37 |  | $9.60 | 0.31% | 472.90M | 9.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸38 |  | $2.88 | 2.13% | 435.13M | 33.95% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸39 |  | $66.10 | 2.02% | 429.91M | 807.97% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸40 |  | $9.84 | 6.26% | 415.42M | 54.72% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸41 |  | $11.59 | -4.33% | 414.75M | 6.92% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸42 |  | $13.10 | 2.02% | 404.35M | -12.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸43 |  | $4.00 | 1.01% | 394.41M | 9.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸44 |  | $15.17 | 1.34% | 382.86M | 4.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸45 |  | $7.16 | 0.14% | 371.20M | 129.12% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸46 |  | $0.31 | 0.00% | 357.69M | -55.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸47 |  | $1.35 | -2.88% | 340.02M | -30.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸48 |  | $8.58 | 3.87% | 306.36M | -40.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸49 |  | $6.21 | -4.02% | 306.04M | 10.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸50 |  | $6.07 | 9.96% | 297.62M | 184.98% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸51 |  | $4.16 | 1.46% | 294.39M | -72.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸52 |  | $5.48 | -0.36% | 268.73M | 216.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸53 |  | $5.27 | -2.23% | 258.61M | -17.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸54 |  | $2.12 | 3.92% | 255.63M | -7.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸55 |  | $4.83 | -10.88% | 249.40M | 71.28% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸56 |  | $5.54 | 1.65% | 241.26M | -6.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸57 |  | $3.95 | -1.50% | 240.77M | -7.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸58 |  | $3.30 | -1.93% | 204.70M | -65.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸59 |  | $7.04 | 0.21% | 203.60M | 372.48% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸60 |  | $9.05 | -3.52% | 199.52M | 118.07% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸61 |  | $1.46 | 0.62% | 182.82M | 62.11% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸62 |  | $14.17 | -2.01% | 182.06M | 34.31% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸63 |  | $1.87 | -14.45% | 176.96M | -33.87% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸64 |  | $3.78 | 3.28% | 167.54M | 111.17% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸65 |  | $3.65 | -2.67% | 155.07M | -49.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸66 |  | $4.62 | -0.86% | 122.03M | -44.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸67 |  | $2.50 | -3.85% | 118.93M | -42.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸68 |  | $2.46 | -3.15% | 109.91M | 66.22% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸69 |  | $2.17 | -0.69% | 107.86M | -85.28% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸70 |  | $3.40 | 3.03% | 105.64M | -12.82% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸71 |  | $2.47 | -5.00% | 103.69M | -42.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸72 |  | $3.07 | -1.60% | 95.50M | -38.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸73 |  | $5.19 | -6.49% | 93.53M | -53.45% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸74 |  | $2.25 | 6.64% | 93.19M | -71.37% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸75 |  | $2.21 | -0.23% | 86.02M | 154.02% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸76 |  | $0.74 | -1.73% | 84.41M | -15.77% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸77 |  | $2.22 | -0.45% | 80.35M | -42.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸78 |  | $1.66 | -0.60% | 80.11M | -14.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸79 |  | $1.67 | -0.89% | 80.05M | -31.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸80 |  | $1.19 | -1.65% | 79.72M | -25.16% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸81 |  | $2.38 | 1.71% | 79.52M | 177.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸82 |  | $1.51 | 0.67% | 77.25M | -51.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸83 |  | $1.55 | -8.28% | 76.02M | 1.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸84 |  | $2.88 | 2.86% | 73.63M | -33.18% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸85 |  | $3.41 | 0.89% | 72.89M | -36.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸86 |  | $2.71 | -2.52% | 68.48M | -66.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸87 |  | $2.28 | -17.99% | 66.73M | -69.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸88 |  | $1.50 | 0.00% | 64.75M | -20.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸89 |  | $0.16 | 2.37% | 59.32M | 121.16% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸90 |  | $3.94 | -5.29% | 58.57M | 1090.33% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸91 |  | $4.17 | 2.46% | 57.17M | -50.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸92 |  | $0.92 | -2.44% | 53.65M | -23.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸93 |  | $1.22 | -3.17% | 53.05M | 11.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸94 |  | $0.55 | -2.07% | 52.29M | -73.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸95 |  | $1.89 | 5.00% | 51.81M | -63.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸96 |  | $1.98 | -1.00% | 51.49M | -74.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸97 |  | $2.95 | 0.34% | 50.04M | 152.14% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸98 |  | $1.12 | -7.44% | 49.82M | -60.28% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸99 |  | $0.61 | -7.58% | 48.00M | -22.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸100 |  | $1.84 | -2.13% | 45.13M | -9.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
